Great Tree Pharmacy Co., Ltd.
TPEX:6469 Lagerbericht
Marktkapitalisierung: NT$23.3b
Great Tree Pharmacy Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6 Great Tree Pharmacy hat ein Gesamteigenkapital von NT$3.4B und eine Gesamtverschuldung von NT$999.1M, wodurch sich der Verschuldungsgrad auf 29.4% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen NT$11.3B bzw. NT$7.9B. Great Tree Pharmacy Das EBIT des Unternehmens beträgt NT$804.8M, so dass der Zinsdeckungsgrad 18.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von NT$1.8B.
Wichtige Informationen
29.4%
Verhältnis von Schulden zu Eigenkapital
Zinsdeckungsgrad 18.8x Bargeld NT$1.75b Eigenkapital NT$3.40b Gesamtverbindlichkeiten NT$7.89b Gesamtvermögen NT$11.30b
Jüngste Berichte zur Finanzlage
Alle Updates anzeigen
Third quarter 2024 earnings released: EPS: NT$1.27 (vs NT$1.26 in 3Q 2023) Nov 11
New minor risk - Shareholder dilution Aug 21
Second quarter 2024 earnings released: EPS: NT$1.29 (vs NT$1.29 in 2Q 2023) Aug 13
Great Tree Pharmacy Co., Ltd. to Report Q2, 2024 Results on Aug 09, 2024 Aug 02
Upcoming dividend of NT$3.60 per share Jul 03
Dividend of NT$3.60 announced Jun 13
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend , Payable on July 31, 2024 Jun 13
First quarter 2024 earnings: EPS and revenues miss analyst expectations May 18
Consensus EPS estimates fall by 13% May 14 Great Tree Pharmacy Co., Ltd. to Report Q1, 2024 Results on May 10, 2024 May 03
Less than half of directors are independent Apr 03
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 06 Great Tree Pharmacy Co., Ltd. announced a financing transaction
New minor risk - Shareholder dilution Dec 23
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Nov 15
New major risk - Earnings quality Aug 12
Great Tree Pharmacy Co., Ltd. Announces Convener of Audit Committee Changes Aug 11
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Aug 11
Consensus EPS estimates fall by 18% Aug 11
Upcoming dividend of NT$4.70 per share at 1.3% yield Jun 28
First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Jun 07
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend for the Year 2022, Payable on July 28, 2023 Jun 06
Great Tree Pharmacy Co., Ltd. Appoints Min-Hsiung Pan as Member of the Audit Committee and the Remuneration Committee Jun 02
Great Tree Pharmacy Co., Ltd. Elects Min-Hsiung Pan as Independent Director Jun 01
Now 23% undervalued May 12
Full year 2022 earnings: EPS misses analyst expectations Mar 01
Price target increased by 7.6% to NT$324 Feb 24
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Nov 16
Less than half of directors are independent Nov 16
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Nov 13
Now 20% undervalued Oct 26 Great Tree Pharmacy Co., Ltd. announced that it has received TWD 220 million in funding from Sugi Holdings Co.,Ltd. Sep 17
Great Tree Pharmacy Co., Ltd. announced that it expects to receive funding from Sugi Holdings Co.,Ltd. Sep 08
Consensus forecasts updated Aug 30
Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Aug 13
Investor sentiment improved over the past week Jul 11
Upcoming dividend of NT$2.57 per share Jun 22
Great Tree Pharmacy Co., Ltd. Announces Cash Dividend, Payable on July 21, 2022 Jun 15
Investor sentiment improved over the past week Jun 10
Less than half of directors are independent May 16
First quarter 2022 earnings released: EPS: NT$1.67 (vs NT$1.04 in 1Q 2021) May 14
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 28
Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution for the Year Ended December 31, 2021 Feb 27
Great Tree Pharmacy Co., Ltd., Annual General Meeting, May 31, 2022 Feb 26
Investor sentiment improved over the past week Feb 24
Third quarter 2021 earnings released: EPS NT$1.51 (vs NT$0.66 in 3Q 2020) Nov 12
Investor sentiment deteriorated over the past week Sep 10
Investor sentiment improved over the past week Aug 24
Second quarter 2021 earnings released: EPS NT$2.20 (vs NT$0.86 in 2Q 2020) Aug 13
Investor sentiment improved over the past week Jul 23
Upcoming dividend of NT$0.99 per share Jul 15
Investor sentiment improved over the past week Jun 24
First quarter 2021 earnings released: EPS NT$1.34 (vs NT$0.92 in 1Q 2020) May 15
Investor sentiment improved over the past week Mar 24
There Are Reasons To Feel Uneasy About Great Tree Pharmacy's (GTSM:6469) Returns On Capital Mar 24
Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution Mar 20
Great Tree Pharmacy Co., Ltd., Annual General Meeting, Jun 24, 2021 Mar 19
Full year 2020 earnings released: EPS NT$3.73 (vs NT$2.77 in FY 2019) Mar 19
New 90-day high: NT$101 Mar 12
Is Great Tree Pharmacy (GTSM:6469) A Risky Investment? Mar 03
Is Great Tree Pharmacy Co., Ltd.'s (GTSM:6469) Stock's Recent Performance A Reflection Of Its Financial Health? Feb 09
Great Tree Pharmacy's (GTSM:6469) Earnings Are Growing But Is There More To The Story? Jan 19
Did You Miss Great Tree Pharmacy's (GTSM:6469) 71% Share Price Gain? Dec 28
Should We Be Excited About The Trends Of Returns At Great Tree Pharmacy (GTSM:6469)? Dec 09
New 90-day high: NT$100.00 Nov 24
Third quarter 2020 earnings released: EPS NT$0.86 Nov 12
New 90-day high - NT$94.50 Aug 24
First half earnings released Aug 13
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 6469Die kurzfristigen Aktiva des Unternehmens (NT$5.9B) übersteigen seine kurzfristigen Passiva (NT$3.5B).
Langfristige Verbindlichkeiten: 6469Die kurzfristigen Vermögenswerte des Unternehmens (NT$5.9B) übersteigen seine langfristigen Verbindlichkeiten (NT$4.4B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 6469 über mehr Barmittel verfügt als seine Gesamtverschuldung.
Schulden abbauen: 6469Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 19.8% auf 29.4% gestiegen.
Schuldendeckung: 6469Die Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (97.4%).
Zinsdeckung: 6469Die Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (18.8x Coverage) gut gedeckt .
Entdecken Sie finanziell stabile Unternehmen Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
